Step by Step
C
Candida albicans — opportunistic, not exogenous
Candida albicans already lives in you as normal flora — in the mouth, GI tract, and vaginal tract. It only causes disease when something disrupts the normal balance: antibiotics wiping out competing bacteria, immunosuppression, or diabetes. On microscopy, it shows pseudohyphae — a key identifying feature.
OT
Oral thrush — white plaques
When Candida overgrows in the mouth, it produces oral thrush: white plaques on the tongue and oral mucosa. This is common in infants, denture wearers, inhaled corticosteroid users (asthma patients), and immunocompromised patients.
VV
Vulvovaginal candidiasis — cottage cheese discharge
In the vaginal tract, Candida overgrowth produces a thick, white, cottage-cheese-like discharge along with intense itching (pruritus) — classically triggered by antibiotic use (which kills the competing lactobacilli), pregnancy, or diabetes.
IC
Invasive candidemia — the dangerous form
In ICU patients — especially those with central venous lines, on broad-spectrum antibiotics, receiving TPN (total parenteral nutrition), or otherwise immunosuppressed — Candida can enter the bloodstream and cause invasive candidemia, a serious systemic infection. Treatment escalates with severity: fluconazole for mild-to-moderate disease, but an echinocandin for invasive or azole-resistant infections.
A patient in the ICU with a central line, on broad-spectrum antibiotics for a week, develops a new fever and blood cultures grow Candida — this is invasive candidemia, treated with an echinocandin rather than fluconazole given the severity and resistance risk.
Applied Walkthrough
1
A patient in the ICU has had a central venous line in place for over a week and has been on broad-spectrum antibiotics the entire time.
2
They develop a new fever, and blood cultures come back growing Candida albicans.
3
Ask: why did this happen, and how should it be treated? The central line, broad-spectrum antibiotics, and ICU setting are exactly the risk factors that let normally-harmless Candida invade the bloodstream — this is invasive candidemia, not a new exposure to a foreign organism.
4
Given the severity of invasive disease, treatment escalates beyond fluconazole to an echinocandin — reflecting the general principle that Candida treatment intensity should match how deep and dangerous the infection has become.
Exam Application
Exams test recognizing Candida's different clinical presentations by host context — oral thrush in infants/inhaled steroid users, vulvovaginal candidiasis after antibiotics, and invasive candidemia in ICU/immunosuppressed patients — and matching severity to the right antifungal (fluconazole for mild-moderate, echinocandin for invasive/resistant disease).
⚠ Common Trap
The most common trap is thinking of Candida as something a patient catches from an outside source, the way you would with most infections. It's normal flora that overgrows when the immune system, competing bacteria, or metabolic regulation weakens — the organism was already there.
✓ Quick Self-Check
1. Why is Candida albicans called an opportunistic pathogen rather than an exogenous one?
Because it's already normal flora living in the mouth, GI tract, and vagina; it only causes disease when normal defenses (immune system, competing bacteria, glucose control) are disrupted.
Tap to reveal / hide
2. What does Candida look like on microscopy?
Pseudohyphae.
Tap to reveal / hide
3. What are the classic triggers for vulvovaginal candidiasis?
Antibiotic use, pregnancy, and diabetes.
Tap to reveal / hide
4. What patient population is at highest risk for invasive candidemia, and why?
ICU patients with central venous lines, broad-spectrum antibiotic use, TPN, or immunosuppression — these disrupt normal flora balance and provide a route into the bloodstream.
Tap to reveal / hide
5. How does antifungal treatment change between mild and invasive Candida infections?
Fluconazole treats mild-to-moderate disease; invasive or azole-resistant candidemia requires an echinocandin.
Tap to reveal / hide